| 摘要 |
The use of reduced nicotinamide adenine dinucleotide phosphate (NADPH) in preparing medicines for the treatment or prevention of cardiovascular and cerebrovascular diseases, and medicines for the treatment or prevention of cardiovascular and cerebrovascular diseases using NADPH as the active ingredient, said cardiovascular and cerebrovascular diseases including thrombosis diseases, hypertension, coronary artery disease, blood vessel hardening, and atherosclerosis. |
